Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
03/2011
03/08/2011US7901943 Materials and methods for controlling isotope effects during fractionation of analytes
03/08/2011US7901942 Method of quantifying membrane protein by mass spectrometry using peptide selection criteria
03/08/2011US7901941 Automated tissue staining system and reagent container
03/08/2011US7901940 Method for measuring recovery of catalytic elements from fuel cells
03/08/2011US7901931 Cell for measuring biological activities and/or physiological parameters of micro-organisms
03/08/2011US7901919 Chimaeric phages
03/08/2011US7901900 quantitatively or qualitatively determine human low molecular weight CD14 with high sensitivity and specificity in a simple manner
03/08/2011US7901899 Method for classifying a microorganism in a biological sample
03/08/2011US7901898 Tuberculosis diagnostic test
03/08/2011US7901897 Methods of making arrays
03/08/2011US7901896 Asbestos exposure, pleural mesothelioma, and osteopontin levels
03/08/2011US7901895 Screening environmental samples such as food, water for beta-N-methylamino-L-alanine (BMAA) associated with risk of nervous system disorders such as dementia, amyotrophic lateral sclerosis
03/08/2011US7901894 Kinase inhibitors
03/08/2011US7901893 NPC1L1 (NPC3) and methods of identifying ligands thereof
03/08/2011US7901892 Methods and compositions for determining the purity of chemically synthesized nucleic acids
03/08/2011US7901887 Qualitative analysis; polymerase chain reaction; in situ fluorescence hybridization; automated screening for gene amplification
03/08/2011US7901886 Solid support comprising immobilized receptors for use in isolating preferential nucleotide sequences in solution
03/08/2011US7901881 Using differentially expressed thyroid (DET) genes as evaluative tools when staging and treating cell proliferative disorders of thyroid
03/08/2011US7901880 Using methylation status/profile of gene sequences as diagnostic tool in detection of cell proliferative disorders
03/08/2011US7901877 Genetic markers and methods for detecting and treating cancers
03/08/2011US7901876 Determining Numb status and Notch activity of tissue samples; disease progression in p53 and/or estrogen receptor backgrounds
03/08/2011US7901875 For determining the concentration of glucose, cholesterol, free fatty acids, triglycerides, proteins, ketones, phenylalanine or enzymes, in a physiological fluid like blood, serum, plasma, saliva, urine
03/08/2011US7901874 Methods for identifying agents for preventing or treating proliferative diseases, and for inhibiting extracellular matrix or α1 type IV collagen
03/08/2011US7901873 Methods for the diagnosis and treatment of bone disorders
03/08/2011US7901871 Composition containing a photoacid generator monomer, substrate coated with the composition, method for synthesizing a compound on a substrate using the composition, and microarray produced according to the method
03/08/2011US7901686 drug screening; reaction mixture includes a hedgehog polypeptide, a patched polypeptide, and a test compound; receptor binding assay
03/08/2011US7901685 Methods for assaying inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion
03/08/2011US7901682 Compositions and methods for the treatment and prevention of cancer, angiogenesis, and inflammation
03/08/2011US7901681 Trypanosome derived apoptotic factors (TAF)
03/08/2011US7901630 Diffraction grating-based encoded microparticle assay stick
03/08/2011US7901629 Cartridge device for blood analysis
03/08/2011US7901626 Fluid handling unit and fluid handling apparatus using same
03/08/2011US7901625 System for performing diabetes self-care
03/08/2011US7901624 Device for automatically adjusting the bacterial inoculum level of a sample
03/08/2011US7901623 Apparatus which analyzes saliva/buccal cell sampling for radiation insult; bioscreening and terrorism
03/08/2011US7901622 Test element with a capillary for transport of a liquid sample
03/08/2011US7901618 Integrated control and distribution system for the decontamination of large volume convoluted configuration spaces
03/08/2011US7901555 Electro-chemical sensor
03/08/2011US7901554 Biosensor
03/08/2011US7901553 Method and system for sensing gas incorporating an integrated reference element
03/08/2011US7901365 Method and apparatus for penetrating tissue
03/08/2011US7901362 Method and apparatus for penetrating tissue
03/08/2011US7900841 Shopping system comprising product item and reading device
03/08/2011US7900526 Defect classification utilizing data from a non-vibrating contact potential difference sensor
03/08/2011US7900504 High pressure fracture tester
03/08/2011US7900496 Method and device for calibration sensors
03/08/2011CA2498565C Composition for treating virus infection disease comprising jab1
03/08/2011CA2468415C Non-human animal model of systemic lupus erythematosus
03/08/2011CA2427645C Diagnosis of pre-eclampsia using pigf with pai-1, pai-2 and leptin
03/08/2011CA2407483C Gas sensor assembly and method
03/08/2011CA2366559C Protein isolation and analysis
03/08/2011CA2329054C A novel polypeptide hormone phosphatonin
03/08/2011CA2323019C Bacteria and yeasts for reducing fusarium head blight in cereals and selection thereof
03/08/2011CA2240516C Novel tyrosine kinase receptors and ligands
03/05/2011CA2714319A1 Process and apparatus for identifying autocatalysts
03/03/2011WO2011026132A2 Methods and compositions for the inhibition of transplant rejection
03/03/2011WO2011026122A2 B7-h4 fusion proteins and methods of use thereof
03/03/2011WO2011026117A1 Use of an immunoregulatory nk cell population for monitoring the efficacy of anti-il-2r antibodies in multiple sclerosis patients
03/03/2011WO2011026081A1 Chitin-binding proteins as biomarkers
03/03/2011WO2011026036A1 Detecting circulating cartilage oligomeric matrix protein in liver cirrhosis
03/03/2011WO2011026031A1 Antibodies that bind tau oligomers
03/03/2011WO2011026017A1 Biomarkers for prediction of major adverse cardiac events and uses thereof
03/03/2011WO2011025986A1 Multi-layer blood component exchange devices, systems, and methods
03/03/2011WO2011025976A2 Methods of detaching and collecting cells
03/03/2011WO2011025919A1 Mirna biomarkers of lung disease
03/03/2011WO2011025917A1 Methods and compositions for diagnosis and prognosis of renal injury and renal failure
03/03/2011WO2011025891A2 Anti-coagulant calibrant infusion fluid source
03/03/2011WO2011025790A1 Macrocyclic hopo chelators
03/03/2011WO2011025736A1 Imaging and evaluating embryos, oocytes, and stem cells
03/03/2011WO2011025711A1 Method of using ligand-free lysing agent in hemoglobin analysis
03/03/2011WO2011025693A1 Small volume test strips with large sample fill ports, supported test strips, and methods of making and using same
03/03/2011WO2011025546A1 1, 2, 3-triazole containing protein kinase sensors
03/03/2011WO2011025542A1 Seromic analysis of ovarian cancer
03/03/2011WO2011025442A1 Method and apparatus for antigen retrieval process
03/03/2011WO2011025366A1 A method of screening agents for their impact on nucleic acid oxidation reactions
03/03/2011WO2011024999A1 Specimen for detecting infiltrative large intestine tumors
03/03/2011WO2011024955A1 Nucleic acid capable of binding to tgf-βii-type receptor, and use thereof
03/03/2011WO2011024912A1 Item arrangement determination device, item arrangement determination method and item arrangement determination program
03/03/2011WO2011024875A1 Polynucleotide derived from novel hepatitis c virus strain and use thereof
03/03/2011WO2011024618A1 Detection of digestive system cancer, stomach cancer, colon cancer, pancreatic cancer, and biliary tract cancer by means of gene expression profiling
03/03/2011WO2011024482A1 Method for measurement of ability of inducing antigen-specific t cells
03/03/2011WO2011024458A1 Method for examining graft versus host disease
03/03/2011WO2011024441A1 Ercc6l as target genes for cancer therapy and diagnosis
03/03/2011WO2011024412A1 Gene and polypeptide relating to breast cancer
03/03/2011WO2011024157A1 Nucleic acid sequences related to cancer
03/03/2011WO2011024107A1 Method for prognosing heart failure
03/03/2011WO2011024006A1 Compound
03/03/2011WO2011023958A1 Screening methods
03/03/2011WO2011023914A1 Proteins used for the diagnosis of lyme borreliosis
03/03/2011WO2011023909A1 Proteins used for the diagnosis of lyme borreliosis
03/03/2011WO2011023874A1 Method for detecting the contamination of two-phase titanium alloys with an alpha phase and a beta phase
03/03/2011WO2011023854A1 Separation-free assay method
03/03/2011WO2011023813A1 Procalcitonin for the prognosis of adverse events
03/03/2011WO2011023786A1 Use of cathepsin h
03/03/2011WO2011023655A1 Microfluidic system and method for producing same
03/03/2011WO2011023421A1 Process analyzer
03/03/2011WO2011023420A1 Water analyzer comprising a pneumatically driven multi-chamber peristaltic pump
03/03/2011WO2011023363A1 Method and device for cell sample diagnosis
03/03/2011WO2011023230A1 Method of extracting mycotoxins from cereal grains
03/03/2011WO2011023102A1 Method for determining the effectiveness of chinese medicine preparation by detecting the transcriptional activity of liver x receptor